0 181

Cited 12 times in

HbA1c for diagnosis and prognosis of gestational diabetes mellitus

DC FieldValueLanguage
dc.contributor.author권자영-
dc.contributor.author김영한-
dc.contributor.author박용원-
dc.contributor.author임종백-
dc.date.accessioned2016-02-04T11:51:38Z-
dc.date.available2016-02-04T11:51:38Z-
dc.date.issued2015-
dc.identifier.issn0168-8227-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/141362-
dc.description.abstractAIMS: HbA1c is a widely used marker in diagnosing type 2 diabetes mellitus (DM), but its clinical utility in diagnosing gestational diabetes mellitus (GDM) is not established. Here, we evaluated the clinical usefulness of HbA1c in diagnosing GDM and predicting the risk of future type 2 DM development among GDM patients. METHODS: This retrospective, cross-sectional study included 321 subjects who underwent 100-g oral glucose tolerance tests (OGTT) during pregnancy. HbA1c and other variables were analyzed to evaluate their diagnostic performance for GDM. To evaluate the clinical usefulness of HbA1c in predicting future type 2 DM development, we classified GDM subjects who had more than 3 months of follow-up data into two subgroups: those who developed postpartum type 2 DM (PDM) and those who did not. RESULTS: HbA1c was significantly higher in the GDM group than in the normal control group. With the 100-g OGTT as reference, HbA1c showed 91.3% sensitivity and 62% specificity at a cut-off value of 5.05% (32mmol/mol) for GDM diagnosis. At a cut-off value of 5.25% (34mmol/mol), sensitivity was 73.6% and specificity was 77.2%. HbA1c levels during pregnancy were higher in those with PDM than in those without PDM (5.91 [41mmol/mol] vs. 5.44% [36mmol/mol], p<0.001). The prognostic value of HbA1c for PDM was evaluated by ROC curve analysis, with sensitivity of 78.6% and specificity of 72.5% at a cut-off value of 5.55% (37mmol/mol). CONCLUSIONS: HbA1c showed high sensitivity with relatively low specificity for diagnosis of GDM in pregnant women and was a potential predictor of PDM. HbA1c may be able to be used as a simple and less invasive alternative screening test for OGTT in GDM patients.-
dc.description.statementOfResponsibilityopen-
dc.format.extent38~43-
dc.relation.isPartOfDiabetes Research and Clinical Practice-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleHbA1c for diagnosis and prognosis of gestational diabetes mellitus-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics & Gynecology (산부인과학)-
dc.contributor.googleauthorSoon Sung Kwon-
dc.contributor.googleauthorJa-Young Kwon-
dc.contributor.googleauthorYong-Won Park-
dc.contributor.googleauthorYoung-Han Kim-
dc.contributor.googleauthorJong-Baeck Lim-
dc.identifier.doi10.1016/j.diabres.2015.07.014-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00246-
dc.contributor.localIdA00730-
dc.contributor.localIdA01581-
dc.contributor.localIdA03403-
dc.relation.journalcodeJ00723-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S016882271500340X-
dc.contributor.alternativeNameKwon, Ja Young-
dc.contributor.alternativeNameKim, Young Han-
dc.contributor.alternativeNamePark, Yong Won-
dc.contributor.alternativeNameLim, Jong Baeck-
dc.contributor.affiliatedAuthorKwon, Ja Young-
dc.contributor.affiliatedAuthorKim, Young Han-
dc.contributor.affiliatedAuthorPark, Yong Won-
dc.contributor.affiliatedAuthorLim, Jong Baeck-
dc.rights.accessRightsnot free-
dc.citation.volume110-
dc.citation.number1-
dc.citation.startPage38-
dc.citation.endPage43-
dc.identifier.bibliographicCitationDiabetes Research and Clinical Practice, Vol.110(1) : 38-43, 2015-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.